APA (7th ed.) Citation

JT, P., A, B., DA, S., RJ, K., MG, F., KS, Y., . . . S, K. (2025). SOX2 utilizes FOXA1 as a heteromeric transcriptional partner to drive proliferation in therapy-resistant prostate cancer. BioRxiv : the preprint server for biology. https://doi.org/10.1101/2025.07.18.664790

Chicago Style (17th ed.) Citation

JT, Phoenix, et al. "SOX2 Utilizes FOXA1 as a Heteromeric Transcriptional Partner to Drive Proliferation in Therapy-resistant Prostate Cancer." BioRxiv : The Preprint Server for Biology 2025. https://doi.org/10.1101/2025.07.18.664790.

MLA (9th ed.) Citation

JT, Phoenix, et al. "SOX2 Utilizes FOXA1 as a Heteromeric Transcriptional Partner to Drive Proliferation in Therapy-resistant Prostate Cancer." BioRxiv : The Preprint Server for Biology, 2025, https://doi.org/10.1101/2025.07.18.664790.